David Ohayon
Plus aucun poste en cours
Profil
David Ohayon worked as a Senior Director-Chemistry at Safe Life Corp., Research Director at KLOX Technologies, Inc., and Vice President-Science at TrioMed Innovations Corp.
He also worked as a Lecturer at McGill University and College Dawson.
Ohayon holds a doctorate degree from Concordia University, which he received in 2002.
Anciens postes connus de David Ohayon
Sociétés | Poste | Fin |
---|---|---|
KLOX TECHNOLOGIES INC | Directeur Technique/Scientifique/R&D | - |
College Dawson | Corporate Officer/Principal | - |
TrioMed Innovations Corp.
TrioMed Innovations Corp. Chemicals: Major DiversifiedProcess Industries TrioMed Innovations Corp. is a company dedicated to developing novel, antimicrobial technologies and products that help prevent the spread of infections and disease. Successor to Triosyn Corp. which was founded in 1992, the company has developed the 'TrioMed Technologies' creating innovative products such as the wound dressing incorporating unique antimicrobial properties and the next-generation in respirator and surgical facemask: the SafeLife B100 N95 Respirator (NIOSH-certified and U.S FDA-cleared). With more than 100 patents and patents pending, the scientific team and engineering groups have successfully harnessed the power of an iodinated resin novel molecular structure providing a non-toxic and more powerful antimicrobial efficacy based on the use of Tri-iodide. TrioMed has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in Vermont U.S.A, the company includes manufacturing facilities and technological centers in both Vermont and Mirabel QC, Canada. | Directeur Technique/Scientifique/R&D | - |
McGill University | Corporate Officer/Principal | - |
Safe Life Corp.
Safe Life Corp. Chemicals: Major DiversifiedProcess Industries Safe Life Corp. develops antimicrobial technology. The company was founded in 2006 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | - |
Formation de David Ohayon
Concordia University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Safe Life Corp.
Safe Life Corp. Chemicals: Major DiversifiedProcess Industries Safe Life Corp. develops antimicrobial technology. The company was founded in 2006 and is headquartered in La Jolla, CA. | Process Industries |
TrioMed Innovations Corp.
TrioMed Innovations Corp. Chemicals: Major DiversifiedProcess Industries TrioMed Innovations Corp. is a company dedicated to developing novel, antimicrobial technologies and products that help prevent the spread of infections and disease. Successor to Triosyn Corp. which was founded in 1992, the company has developed the 'TrioMed Technologies' creating innovative products such as the wound dressing incorporating unique antimicrobial properties and the next-generation in respirator and surgical facemask: the SafeLife B100 N95 Respirator (NIOSH-certified and U.S FDA-cleared). With more than 100 patents and patents pending, the scientific team and engineering groups have successfully harnessed the power of an iodinated resin novel molecular structure providing a non-toxic and more powerful antimicrobial efficacy based on the use of Tri-iodide. TrioMed has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in Vermont U.S.A, the company includes manufacturing facilities and technological centers in both Vermont and Mirabel QC, Canada. | Process Industries |
KLOX Technologies, Inc.
KLOX Technologies, Inc. Medical SpecialtiesHealth Technology KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada. | Health Technology |